Immutep Limited (IMMP) - News Archive

Showing 3 of 3 results.

Immutep Limiteds Promising Safety Data from IMP761 Phase I Trial A Glimmer of Hope Amidst Market Struggles

Immutep Limited (ASX: IMM; NASDAQ: IMMP), a notable player in the field of biotechnology focusing on LAG-3 immunotherapies, recently announced encouraging initial safety data from its Phase I clinical trial evaluating I...

Dec 29, 2024 • Major Pharmaceutical Preparations Industry Clinical Study Immutep Announces Details Here Immutep Ltd Here Ba

Immuteps Immune-Boosting Cancer Therapies Triumph Despite Market Challenges

Immutep Limited, a pioneering biotechnology company focused on developing effective immunotherapy treatments for cancer, is making waves in the medical field with its ground-breaking research and clinical results. Despi...

Jul 3, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Immutep Announces Details Here Baird Baird Limited

Immutep Shares Experience Price Decline but Remain Promising Investment, Say Analysts

Immutep Ltd (ASX: IMM), an Australian healthcare company specializing in the development of novel LAG-3 immunotherapies, has witnessed a significant decline in its stock price over the past few days. The market reaction...

Jun 28, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Immutep Ltd Here Immutep Immutep Limited Investors